Leukemia, Lymphoid
Also known as: Lymphoid Leukemia / Lymphoid leukemia, unspecified / Lymphoid leukemia, unspecified not having achieved remission / Lymphoid leukemia (morphologic abnormality) / Lymphoid leukemia (disorder) / Leukemia lymphoid / Lymphoid leukaemia / Leukaemia lymphoid / Leukemia lymphocytic / Lymphocytic leukemia / Lymphocytic leukaemia / Leukaemia lymphocytic / Lymphatic leukemia / Lymphatic leukaemia / Leukemia lymphatic / Unspecified lymphoid leukaemia / Unspecified lymphoid leukemia / Lymphoblastic leukemia NOS / Leukaemia lymphatic / Lymphoblastic leukaemia NOS
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00098 | Antithymocyte immunoglobulin (rabbit) | 1 | Completed | 1 |
DB01008 | Busulfan | 1 | Completed | 1 |
DB01254 | Dasatinib | 1 | Terminated | 1 |
DB01073 | Fludarabine | 1 | Completed | 1 |
DB00563 | Methotrexate | 1 | Completed | 1 |
DB00087 | Alemtuzumab | 2 | Completed | 1 |
DB00126 | Ascorbic acid | 2 | Completed | 1 |
DB06769 | Bendamustine | 2 | Completed | 1 |
DB06769 | Bendamustine | 2 | Terminated | 1 |
DB09052 | Blinatumomab | 2 | Not Yet Recruiting | 1 |
DB09052 | Blinatumomab | 2 | Recruiting | 1 |
DB12483 | Copanlisib | 2 | Terminated | 1 |
DB00987 | Cytarabine | 2 | Completed | 1 |
DB00987 | Cytarabine | 2 | Suspended | 1 |
DB00694 | Daunorubicin | 2 | Completed | 1 |
DB01234 | Dexamethasone | 2 | Completed | 1 |
DB00997 | Doxorubicin | 2 | Unknown Status | 1 |
DB00099 | Filgrastim | 2 | Completed | 1 |
DB01073 | Fludarabine | 2 | Completed | 1 |
DB00480 | Lenalidomide | 2 | Completed | 2 |
DB01042 | Melphalan | 2 | Completed | 1 |
DB01204 | Mitoxantrone | 2 | Suspended | 1 |
DB00688 | Mycophenolate mofetil | 2 | Completed | 1 |
DB17472 | Pirtobrutinib | 2 | Active Not Recruiting | 1 |
DB00073 | Rituximab | 2 | Completed | 1 |
DB00073 | Rituximab | 2 | Terminated | 1 |
DB00020 | Sargramostim | 2 | Completed | 1 |
DB17186 | Carlecortemcel-L | 2 / 3 | Completed | 1 |
DB09052 | Blinatumomab | Not Available | Not Yet Recruiting | 1 |